How are the pharmaceutical companies that lay out industrial cannabis progressing?

Pharmaceutical Network Market Analysis: Industrial cannabis can be said to be a very fast growth rate in the pharmaceutical segment in recent years.
so far, there are more than 40 pharmaceutical companies in this area.
, how are these projects progressing? Judging from the announcement that the progress of the project has been disclosed, one batch is still advancing and one batch has been "cool".
batch has been "cool" on July 24 this year, Huaren Pharmaceuticals decided to end the industrial cannabis project.
is that the economic situation at home and abroad, market environment, etc. have changed greatly.
March 2019, Huaren Pharmaceuticals signed the Cooperation Framework Agreement with Yunnan Suma and Hou Jie, and the three parties intend to build an industrial cannabis green factory in Yunnan to build China's first industrial cannabis greenhouse greenhouse planting base.
on April 26, 2019, the three-way Yunnan Hanhua Industrial Cannabis Cultivation Co., Ltd. obtained a business license.
June 12, Ercon Pharmaceuticals also announced that the parties agreed to terminate the Agreement of Intent on Cooperation because the intended partners of the final investment target of the proposed fund could not agree on the valuation of the subject matter.
In March 2019, Erkang Pharmaceuticals signed the Agreement of Intent to Cooperate with Yuangui Assets and Suma Bio, and the Company and Yuangui Asset intend to set up an equity investment fund, the fund size is tentatively set at no more than 52.5 million yuan, to subscribe for no more than 10% of the equity of Suma Bio.
Pharmaceuticals and Hemp Bio intends to carry out joint research and application in the field of industrial cannabis application to promote the application of the company's new medicinal accessories.
Also on April 28, Shouxian Valley announced that due to the failure of Yunnan Shouxian Valley to obtain an industrial cannabis cultivation license, the project has not made any substantial progress, the company and Shunxian shares signed a termination of investment cooperation agreement, the cancellation of the established Yunnan Shouxian Valley Company.
in addition to the "high-quality new varieties of cannabis breeding and its active ingredient cannabidiol API efficient preparation of key technology development" research project, Shouxian Valley has no industrial cannabis-related business.
are still pushing forward although some of the enterprise's projects have cooled, but there are also ongoing projects.
For example, Renhe Pharmaceuticals mentioned in its semi-annual report 2020 that it launched a non-public share refinancing project in April this year, raising no more than 833.85 million yuan for four projects, such as the Renhe Xianghe Industrial Cannabis Integrated Use Industry Project, to expand the work of the large health industry and the emerging industrial cannabis industry.
Fuan Pharmaceuticals' 2020 semi-annual report shows that the company has completed the acquisition of Red Realty, the next step, will actively promote the construction of its medical marijuana project completed on time, as soon as possible into operation and generate benefits, to complete this year's profit targets.
it is understood that Red Realty owns a site approved for cultivation and processing licensing for medical cannabis cultivation and processing, and intends to expand its research and development and production base for medical cannabis and CBD products on the site.
also mentioned in its 2020 half-yearly report that the first half of this year steadily expanded the area under cultivation of industrial cannabis, on the basis of successful trials in the previous year.
addition, the construction of an industrial cannabis extraction and processing base in Chuxiong, Yunnan Province is progressing smoothly, the development of various types of end products is also being carried out in an orderly manner, and the expansion of new business is progressing steadily as planned.
addition, Zixin Pharmaceuticals in the field of industrial cannabis layout will be the next city.
introduced industrial cannabis seeds from its Dutch subsidiary Fytagoras into the country in the first half of 2020, has completed the introduction of three types of industrial cannabis seeds, and has carried out the cultivation of scientific and technological greenhouse seeds in Gannan County, Qiqihar City, Heilongjiang Province.
At the same time, the company plans to develop products with industrial cannabis as the main raw material and to provide other enterprises with technical services related to the cultivation of industrial cannabis crops, using the techniques of breeding, cultivation, bioactive ingredient research and compound extraction of industrial cannabis from its Dutch subsidiary, so as to promote the company's industrial layout in the domestic industrial cannabis sector as soon as possible.